Rovin Capital Bristol Myers Squibb CO Put Options Transaction History
Rovin Capital
- $244 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.44 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.5 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.66 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.55 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...